共 136 条
[1]
Dano K(2005)Plasminogen activation and cancer Thromb Haemost 93 676-681
[2]
Behrendt N(2000)The plasminogen activation system in tumor growth, invasion, and metastasis Cell Mol Life Sci 57 25-40
[3]
Hoyer-Hansen G(2003)Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins Biol Chem 384 1119-1131
[4]
Andreasen PA(2002)uPAR: a versatile signaling orchestrator Nat Rev Mol Cell Biol 3 932-943
[5]
Egelund R(2006)The urokinase receptor: a ligand or a receptor? Story of a sociable molecule Cell Mol Life Sci 63 1028-1037
[6]
Petersen HH(2004)The urokinase plasminogen activator system: role in malignancy Curr Pharm Des 10 39-49
[7]
Reuning U(2004)Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer Thromb Haemost 91 450-456
[8]
Magdolen V(2000)The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients Cancer Res 60 636-643
[9]
Hapke S(2000)New ELISA for quantification of human urokinase receptor (CD87) in cancer Int J Oncol 17 827-834
[10]
Blasi F(2001)Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours Br J Cancer 85 85-92